% Survival (P)

aHR (P)

Living Donor

T&B FCXM

82.5

vs. T AHG CDCXM &B

81.1 (0.07)

1.0 (.56)

vs. Other

80.3 (0.01)

1.1 (.04)

Deceased Donor

T&B FCXM

70.8

vs. T AHG CDCXM &B

68.6 (0.001)

1.1 (0.0006)

vs. Other

69.1 (0.002)

1.1 (0.001)
Produced from OPTN Standard Transplant Analysis and Research Files for transplants performed in 1995–2009 [48], Xiao H and Lentine KL, 2011.
Table 1: Five year graft survival after a negative crossmatch, stratified by
technique (1995 –2009).